Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
3
×
clinical trials
fda
life sciences
national
national blog main
biotech
eli lilly
europe blog main
national top stories
new york blog main
san francisco blog main
san francisco top stories
abaloparatide
abbvie
abeona therapeutics
achaogen
affordable care act
allergan
alnylam pharmaceuticals
alzheimer's
astrazeneca
biohaven
biosimilar
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
brexanolone
celiac disease
cgpr
chris collins
coherus biosciences
cydan development
deals
detroit blog main
detroit top stories
egfr
europe top stories
european commission
What
wins
3
×
nod
adults
allergan
alzheimer’s
amgen
amgen’s
approval
approved
bio
carries
class
congress
democrats
developed
divided
drug
elections
europe
european
fallout
fda
heart
losses
marketing
medicine
medicines
midterm
migraine
monday
new
osteoporosis
panel
pill
plenty
political
postpartum
raise
risk
roundup
Language
unset
Current search:
amgen
×
wins
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel